- Symbol
- SIBN
- Venue
- NASDAQ GLOBAL MARKET
- Segment MIC
- XNMS
- ISIN
- US8257041090
- Trading currency
- USD
XNMS:SIBN — listed on NASDAQ GLOBAL MARKET
SI-BONE, Inc. develops and commercializes medical devices for the treatment of sacroiliac (SI) joint dysfunction. The company’s primary product is the iFuse Implant System, which is used in minimally invasive surgical procedures to stabilize the SI joint and alleviate pain. SI-BONE serves healthcare providers and patients experiencing chronic low back pain associated with SI joint dysfunction, primarily in the United States and select international markets. The company focuses on providing diagnostic and treatment solutions that improve patient outcomes for those suffering from SI joint-related conditions.